메뉴 건너뛰기




Volumn 96, Issue 3, 2012, Pages 451-458

Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma

Author keywords

[No Author keywords available]

Indexed keywords

CANCER TESTIS ANTIGEN; GLYCOPROTEIN GP 100; MELANOMA ANTIGEN 3; MELANOMA ANTIGEN 4; MELANOMA ANTIGEN C1; MONOPHENOL MONOOXYGENASE; NY ESO 1 ANTIGEN; UNCLASSIFIED DRUG;

EID: 84857067030     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300432     Document Type: Article
Times cited : (22)

References (37)
  • 2
    • 57449091278 scopus 로고    scopus 로고
    • Ocular melanoma: Relatively rare but requiring respect
    • Shields CL, Shields JA. Ocular melanoma: relatively rare but requiring respect. Clin Dermatol 2009;27:122-33.
    • (2009) Clin Dermatol , vol.27 , pp. 122-133
    • Shields, C.L.1    Shields, J.A.2
  • 3
    • 0036845612 scopus 로고    scopus 로고
    • Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites
    • Tuomaala S, Eskelin S, Tarkkanen A, et al. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanomas in whites. Invest Ophthalmol Vis Sci 2002;43:3399-408. (Pubitemid 35334346)
    • (2002) Investigative Ophthalmology and Visual Science , vol.43 , Issue.11 , pp. 3399-3408
    • Tuomaala, S.1    Eskelin, S.2    Tarkkanen, A.3    Kivela, T.4
  • 4
    • 61449129472 scopus 로고    scopus 로고
    • Mortality after uveal and conjunctival melanoma: Which tumour is more deadly?
    • Kujala E, Tuomaala S, Eskelin S, et al. Mortality after uveal and conjunctival melanoma: which tumour is more deadly? Acta Ophthalmol 2009;87:149-53.
    • (2009) Acta Ophthalmol , vol.87 , pp. 149-153
    • Kujala, E.1    Tuomaala, S.2    Eskelin, S.3
  • 5
  • 6
    • 67349216128 scopus 로고    scopus 로고
    • Effectiveness of treatments for metastatic uveal melanoma
    • Augsburger JJ, Correa ZM, Shaikh AH. Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 2009;148:119-27.
    • (2009) Am J Ophthalmol , vol.148 , pp. 119-127
    • Augsburger, J.J.1    Correa, Z.M.2    Shaikh, A.H.3
  • 7
    • 63049123398 scopus 로고    scopus 로고
    • Quality of evidence about effectiveness of treatments for metastatic uveal melanoma
    • discussion 135-7
    • Augsburger JJ, Correa ZM, Shaikh AH. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. Trans Am Ophthalmol Soc 2008;106:128-35; discussion 135-7.
    • (2008) Trans Am Ophthalmol Soc , vol.106 , pp. 128-135
    • Augsburger, J.J.1    Correa, Z.M.2    Shaikh, A.H.3
  • 10
    • 70350121598 scopus 로고    scopus 로고
    • Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8(+) cytotoxic, tumor-specific T cells
    • Bosch JJ, Iheagwara UK, Reid S, et al. Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8(+) cytotoxic, tumor-specific T cells. Cancer Immunol Immunother 2010;59:103-12.
    • (2010) Cancer Immunol Immunother , vol.59 , pp. 103-112
    • Bosch, J.J.1    Iheagwara, U.K.2    Reid, S.3
  • 13
    • 34447508326 scopus 로고    scopus 로고
    • Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors
    • Velazquez EF, Jungbluth AA, Yancovitz M, et al. Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors. Cancer Immun 2007;7:11-17.
    • (2007) Cancer Immun , vol.7 , pp. 11-17
    • Velazquez, E.F.1    Jungbluth, A.A.2    Yancovitz, M.3
  • 14
    • 63549100184 scopus 로고    scopus 로고
    • Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma
    • Nicholaou T, Ebert LM, Davis ID, et al. Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma. Clin Cancer Res 2009;15:2166-73.
    • (2009) Clin Cancer Res , vol.15 , pp. 2166-2173
    • Nicholaou, T.1    Ebert, L.M.2    Davis, I.D.3
  • 15
    • 79954586180 scopus 로고    scopus 로고
    • Genetics of uveal melanoma and cutaneous melanoma: Two of a kind?
    • van den Bosch T, Kilic E, Paridaens D, et al. Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract 2010;2010:360136.
    • (2010) Dermatol Res Pract , vol.2010 , pp. 360136
    • Van Den Bosch, T.1    Kilic, E.2    Paridaens, D.3
  • 18
    • 0030816455 scopus 로고    scopus 로고
    • Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease
    • Chen PW, Murray TG, Uno T, et al. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease. Clin Exp Metastasis 1996;15:509-18.
    • (1996) Clin Exp Metastasis , vol.15 , pp. 509-518
    • Chen, P.W.1    Murray, T.G.2    Uno, T.3
  • 21
    • 79251593379 scopus 로고    scopus 로고
    • Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate
    • Svobodová S, Browning J, MacGregor D, et al. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. Eur J Cancer 2011;47:460-9.
    • (2011) Eur J Cancer , vol.47 , pp. 460-469
    • Svobodová, S.1    Browning, J.2    MacGregor, D.3
  • 22
    • 33746224212 scopus 로고    scopus 로고
    • Desmoplastic melanoma: Comparison of expression of differentiation antigens and cancer testis antigens
    • DOI 10.1097/01.cmr.0000222588.22493.3f, PII 0000839020060800000010
    • Lim E, Browning J, MacGregor D, et al. Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens. Melanoma Res 2006;16:347-55. (Pubitemid 44090179)
    • (2006) Melanoma Research , vol.16 , Issue.4 , pp. 347-355
    • Lim, E.1    Browning, J.2    MacGregor, D.3    Davis, I.D.4    Cebon, J.S.5
  • 23
    • 0031757416 scopus 로고    scopus 로고
    • High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma
    • de Vries TJ, Trancikova D, Ruiter DJ, et al. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma. Br J Cancer 1998;78:1156-61. (Pubitemid 28479143)
    • (1998) British Journal of Cancer , vol.78 , Issue.9 , pp. 1156-1161
    • De Vries, T.J.1    Trancikova, D.2    Ruiter, D.J.3    Van Muijen, G.N.P.4
  • 24
    • 0035159576 scopus 로고    scopus 로고
    • Expression of gp100, MART-I, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: Implications for diagnosis and immunotherapy. A study conducted by the EORTC melanoma cooperative group
    • DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH729>3.0.CO;2-D
    • de Vries TJ, Smeets M, de Graaf R, et al. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group. J Pathol 2001;193:13-20. (Pubitemid 32051107)
    • (2001) Journal of Pathology , vol.193 , Issue.1 , pp. 13-20
    • De Vries, T.J.1    Smeets, M.2    De Graaf, R.3    Hou-Jensen, K.4    Brocker, E.B.5    Renard, N.6    Eggermont, A.M.M.7    Van Muijen, G.N.P.8    Ruiter, D.J.9
  • 26
    • 3042739497 scopus 로고    scopus 로고
    • Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine
    • Valmori D, Dutoit V, Ayyoub M, et al. Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine. Cancer Immun 2003;3:15-29.
    • (2003) Cancer Immun , vol.3 , pp. 15-29
    • Valmori, D.1    Dutoit, V.2    Ayyoub, M.3
  • 28
    • 0031952899 scopus 로고    scopus 로고
    • Conjunctival melanoma
    • DOI 10.1016/S0039-6257(97)00122-7, PII S0039625797001227
    • Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998;42:321-50. (Pubitemid 28092772)
    • (1998) Survey of Ophthalmology , vol.42 , Issue.4 , pp. 321-350
    • Seregard, S.1
  • 30
    • 79955008528 scopus 로고    scopus 로고
    • Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma
    • Dratviman-Storobinsky O, Cohen Y, Frenkel S, et al. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma. Invest Ophthalmol Vis Sci 2010;51:6180-2.
    • (2010) Invest Ophthalmol Vis Sci , vol.51 , pp. 6180-6182
    • Dratviman-Storobinsky, O.1    Cohen, Y.2    Frenkel, S.3
  • 31
    • 36248941589 scopus 로고    scopus 로고
    • Prognostic significance of histopathology of primary conjunctival melanoma in caucasians
    • DOI 10.1080/02713680701648019, PII 785404303
    • Tuomaala S, Toivonen P, Al-Jamal R, et al. Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr Eye Res 2007;32:939-52. (Pubitemid 350135723)
    • (2007) Current Eye Research , vol.32 , Issue.11 , pp. 939-952
    • Tuomaala, S.1    Toivonen, P.2    Al-Jamal, R.3    Kivela, T.4
  • 32
    • 7244225178 scopus 로고    scopus 로고
    • Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanomas
    • 2204
    • Anassatsiou G, Esser M, Bader E, et al. Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanomas. Melanoma Res 2204;14:381-5.
    • Melanoma Res , vol.14 , pp. 381-385
    • Anassatsiou, G.1    Esser, M.2    Bader, E.3
  • 33
    • 79953276590 scopus 로고    scopus 로고
    • Detection of M2 macrophages in uveal melanoma and relation with survival
    • Bronkhurst IH, Long LV, Jordanova ES, et al. Detection of M2 macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Sci 2011;52:643-50.
    • (2011) Invest Ophthalmol Sci , vol.52 , pp. 643-650
    • Bronkhurst, I.H.1    Long, L.V.2    Jordanova, E.S.3
  • 34
    • 33646083008 scopus 로고    scopus 로고
    • Directions in the immune targeting of cancer: Lessons learned from the cancer-testis Ag NY-ESO-1
    • Nicholaou T, Ebert L, Davis ID, et al. Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1. Immunol Cell Biol 2006;8:303-17.
    • (2006) Immunol Cell Biol , vol.8 , pp. 303-317
    • Nicholaou, T.1    Ebert, L.2    Davis, I.D.3
  • 35
    • 77958543711 scopus 로고    scopus 로고
    • Expression of MCSP and PRAME in conjunctival melanoma
    • Westekemper H, Karimi S, Süsskind D, et al. Expression of MCSP and PRAME in conjunctival melanoma. Br J Ophthalmol 2010;94:1322-7.
    • (2010) Br J Ophthalmol , vol.94 , pp. 1322-1327
    • Westekemper, H.1    Karimi, S.2    Süsskind, D.3
  • 36
    • 79954455826 scopus 로고    scopus 로고
    • Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetylase inhibitor MGCD0103
    • Moreno-Bost A, Szmania S, Stone K, et al. Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetylase inhibitor MGCD0103. Cytotherapy 2011;13:618-28.
    • (2011) Cytotherapy , vol.13 , pp. 618-628
    • Moreno-Bost, A.1    Szmania, S.2    Stone, K.3
  • 37
    • 65249110495 scopus 로고    scopus 로고
    • In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells
    • Cunneen TS, Conway RM, Madigan MC. In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. Arch Ophthalmol 2009;127:414-20.
    • (2009) Arch Ophthalmol , vol.127 , pp. 414-420
    • Cunneen, T.S.1    Conway, R.M.2    Madigan, M.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.